ROCEPHIN KIT Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Rocephin Kit, and what generic alternatives are available?
Rocephin Kit is a drug marketed by Hoffmann La Roche and is included in one NDA.
The generic ingredient in ROCEPHIN KIT is ceftriaxone sodium; lidocaine. There are twenty-six drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.
Summary for ROCEPHIN KIT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 106 |
| Clinical Trials: | 20 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ROCEPHIN KIT at DailyMed |
Recent Clinical Trials for ROCEPHIN KIT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Melbourne Health | Phase 3 |
| University of Malaya | Phase 3 |
| Changi General Hospital | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for ROCEPHIN KIT
US Patents and Regulatory Information for ROCEPHIN KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann La Roche | ROCEPHIN KIT | ceftriaxone sodium; lidocaine | INJECTABLE;INJECTION | 050585-006 | May 8, 1996 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Hoffmann La Roche | ROCEPHIN KIT | ceftriaxone sodium; lidocaine | INJECTABLE;INJECTION | 050585-007 | May 8, 1996 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
